Pharm Womens health Part 1

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/47

encourage image

There's no tags or description

Looks like no tags are added yet.

Last updated 10:22 PM on 10/13/26
Name
Mastery
Learn
Test
Matching
Spaced
Call with Kai
Chat

No analytics yet

Send a link to your students to track their progress

48 Terms

1
New cards

Drug absorption differences in women

longer gastric emptying time

absorption affected by estrogen

lower levels of alcohol dehydrogenase

2
New cards

Drug distribution difference in women

lower body weights and BMIs

higher proportion of fats, lipophilic drugs more absorbed

lower levels of circulating lipophilic drugs

3
New cards

Fiber and estrogen PMS

fiber rich diet with less than 20% calories from fat can lower estrogen and curb side effects

4
New cards

Meds for PMS and PMDD

alprazolam (benzo), danezol (androgen), ibuprofen, SSRIs, herbals (primrose oil, chaste tree berry, calcium and magnesium salts, vitamin E, B

5
New cards

Herbals that can cause AUB

garlic, gingko bilboa, ginseng, soy, st johns wort

6
New cards

dysfunctional uterine bleeding treatment

correct volume status

IV conjugate estrogen therapy or PO for nonsevere cases

7
New cards

ADRS of high dose estrogen

N/v, HA, fluid retention, thrombosis, MI, stroke

8
New cards

caution for estrogen

liver disease, over 35 and smoking or previous thromboembolic event or estrogen dependent tumor

9
New cards

Treatment for heavy bleeding

levonorgestrel IUD called Mirena

10
New cards

Endometrial hyperplasia without atypica tx

cyclic or continuous progestins

11
New cards

OCP and cervical cancer

they DO NOT reduce the risk of cervical cancer

12
New cards

Estrogen and FSH

suppresses release of FSH and LH until ovulation when it is released

13
New cards

when does progesterone rise

after ovulation

14
New cards

OCP dose goal

lowest amount tolerated

15
New cards

Low dose monophasic OCP

allows menses 4x/year, breakthrough bleeding possible

16
New cards

multiphasic pills

used for regular monthly cycles

best used for treating menstrual migraines

more likely to have breakthrough bleeding

17
New cards

progesterone only pills

affected only when taken strictly at same time

do not suppress HPA axis

no withdrawal breaks

18
New cards

COCP

combine estrogen and progestin

suppress HPA axis to prevent ovulation

monthly withdrawal bleeding

19
New cards

low dose COCP

may be used in continuous cycle with 2-3 months on and then one week off for bleeding to occur

20
New cards

estrogen containing OCP contraindications

hx of CVA, migraine with aura, heart or liver disease, estorgen sensitive cancers, clotting disorders, DVT, Factor V, undiagnosed uterine bleeding or high breast cancer risk

21
New cards

estrogen and progesterone components dosing

estrogen in mcg and progesterone in mg

22
New cards

estrogens commonly used in BC

Mestranol, ethinyl estradiol and estropipate

23
New cards

progesterones commonly used in BC

levonorgestrel, norgestimate, norethindrone, desogestrel, and drospirenone, ethynodiol diacetate, medroxyprogesterone and entonogestrel

24
New cards

estrogen effects

suppresses FSH

potentiate progestin to suppress LH to halt follicle growth

stabilize endometrial lining

inhibits ovulation by suppression of FSH and LH

inhibition of implantation in high dose form

25
New cards

Progestins MOA

halts follicle growth

hostile cervical environment to hampers sperm

implantation inhibition

alters mid cycle surge of FSH and LH to prevent ovulation

26
New cards

COC uses

cycle regulation, contraception, acne relief, headaches

27
New cards

Estrogen excess adrs

nausea, edema, cramps, depression

lactation suppression, breast tenderness, CVA

thrombosis, hepatic adenoma, weight gain

28
New cards

estrogen deficiency adrs

hot flashes, spotting, decreased libido, drug vaginal mucosa and depression

29
New cards

progestin excess adrs

fatigue, HTN, decreased libido, acne, weight gain, hair loss

30
New cards

progestin deficiency adrs

breakthrough bleeding, heavy flow, weight loss, dysmenorrhea, delayed menses onset

31
New cards

general adrs of OCP

hypercoag, liver abnormalities, stimulation of estrogen sensitive cells

32
New cards

Black box warning for COC

women over 35 who smoke increases serious CV events

33
New cards

OCP interactions/increase metabolism

interferes with tamoxifen

anticonvulsants

PO antibiotics like penicillins

rifampin

St johns wort

griseofulvin

34
New cards

Transdermal contraceptive

contain estrogen and progesterone like ortho evra

35
New cards

transdermal contraceptive moa

thickening of cervical mucus

regulation of period

increased risk of thromboembolism

NO first pass metabolism, less interactions

lower doses required

36
New cards

transdermal contraception adrs

contact dermatitis, skin hyperpigmentation and irritation

37
New cards

transdermal contraception education

replaced weekly

3 weeks on one week off for bleeding

less reliable in women over 200 pounds

breakthrough bleeding more common with this method over PO

38
New cards

Injectable Contraceptives

progestin only for 2 months or combined effective for 1 month

39
New cards

injectable progestin only MOA

thickens cervical mucus

NOT for IV, only IM

40
New cards

injectable contraceptives adrs

progestin only-no CV events, acne, liver toxicity, decreased libido, elevated BP

41
New cards

Disadvantages of injectables

pain, weight gain and irregular menses, decreased bone density

42
New cards

injectables and wash out period

period of 4 weeks before elective surgery, wait 2 weeks to restart after sx

43
New cards

progestin only protective effects

PID, seizurea, myoma and endometriosis

44
New cards

Depo Provera Shot

progestin only injection taken once every 12 weeks; .3% typical and perfect; higher rate of amenorrhea, spotting, weight gain, mood swings; longer return to fertility

45
New cards

subdermal implantable contraceptives

progesterone agents with no first pass, effective for 3 years

46
New cards

subdermal implant adrs

irregular bleeding, weight gain, acne

47
New cards

intravaginal Rings

NuvaRing 35 days of active use, ethinyl estradiol and etonogestrel, suppresses ovaries locally

48
New cards

spermacide do nots

nonoxynol-9 active agent, do not use in patients with HIV exposure